CHerenkov Light mOdulE for time-of-flight Positron Emission Tomography
Time-of-flight positron emission tomography (TOF-PET) is the standard-of-care in cancer detection. TOF-PET scanners’ performance is dependent on the radiation detectors they use. Improving time and spatial detection features in su...
Time-of-flight positron emission tomography (TOF-PET) is the standard-of-care in cancer detection. TOF-PET scanners’ performance is dependent on the radiation detectors they use. Improving time and spatial detection features in such detectors will dramatically impact the diagnostic capacity of TOF-PET systems.
The goal of this project is to build a gamma detector concept for TOF-PET able to improve the time resolution and spatial segmentation of state-of-the-art detectors by a factor of up to 7 and 10, respectively, without additional production costs. CHLOE-PET is a forward-looking gamma detector design for TOF-PET able to exploit the new photodetector technologies that are currently under development and will become available within the next 5-to-10 years.
The novelty of the proposed design lies in using Cherenkov light as a prompt time source, using an innovative geometry optimized to maximize light collection, and employing photodetectors with small pixel pitch. This project is the first attempt to build a detector module scalable to a full-size system that can be used in a hospital setting. The CHLOE-PET detector will consist of bismuth germanate (BGO) crystals with 12 mm thickness and will combine the readout of scintillation and Cherenkov light. CHLOE-PET will provide an effective 3D segmentation of 2x2x2 mm3, an intrinsic photon time spread of 20 ps, and no intrinsic radiation background (unlike state-of-the-art TOF-PET detectors).
Such improvements will allow increasing the signal-to-noise ratio of images by >2-fold, to be able to detect lesions of 2 mm size (>3 times the current performance), to build portable high-performance organ-dedicated TOF-PET systems, and to universalize the use of dynamic TOF-PET studies. The combination of these outcomes will provide significantly better diagnostic capabilities in a range of fields such as oncology, neurology, or cardiology, among others, and ultimately boost treatment efficacy and patient comfort.ver más
Seleccionando "Aceptar todas las cookies" acepta el uso de cookies para ayudarnos a brindarle una mejor experiencia de usuario y para analizar el uso del sitio web. Al hacer clic en "Ajustar tus preferencias" puede elegir qué cookies permitir. Solo las cookies esenciales son necesarias para el correcto funcionamiento de nuestro sitio web y no se pueden rechazar.
Cookie settings
Nuestro sitio web almacena cuatro tipos de cookies. En cualquier momento puede elegir qué cookies acepta y cuáles rechaza. Puede obtener más información sobre qué son las cookies y qué tipos de cookies almacenamos en nuestra Política de cookies.
Son necesarias por razones técnicas. Sin ellas, este sitio web podría no funcionar correctamente.
Son necesarias para una funcionalidad específica en el sitio web. Sin ellos, algunas características pueden estar deshabilitadas.
Nos permite analizar el uso del sitio web y mejorar la experiencia del visitante.
Nos permite personalizar su experiencia y enviarle contenido y ofertas relevantes, en este sitio web y en otros sitios web.